Clarinex Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)
Condition:   AllergiesInterventions:   Drug: Desloratadine;   Drug: Zyrtec® (cetirizine)Sponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2008 Category: Research Source Type: clinical trials

Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Condition:   AllergiesInterventions:   Drug: Desloratadine;   Drug: Zyrtec® (cetirizine)Sponsor:   Merck Sharp & Dohme Corp.Completed - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2008 Category: Research Source Type: clinical trials

Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)
Condition:   AllergiesInterventions:   Drug: Desloratadine;   Drug: Zyrtec® (cetirizine)Sponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2008 Category: Research Source Type: clinical trials

Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Condition:   AllergiesInterventions:   Drug: Desloratadine;   Drug: Zyrtec® (cetirizine)Sponsor:   Merck Sharp & Dohme Corp.Completed - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2008 Category: Research Source Type: clinical trials